![John Houston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 9 M $ al 31/05/2026
John G. Houston ocupa el cargo de Presidente, Consejero Delegado y Director en Arvinas, Inc. y Presidente, Consejero Delegado y Director en Arvinas Operations, Inc. (una filial de Arvinas, Inc.). También forma parte del consejo de NextCure, Inc, Cybrexa, Inc y Oerth Bio LLC. John G. Houston ocupó anteriormente el cargo de Vicepresidente Senior de Descubrimiento de Especialidades en Bristol Myers Squibb Co. y de Jefe de la Unidad de Descubrimiento de Especialidades en GlaxoSmithKline Research & Development Ltd. Se doctoró en la Universidad de Glasgow y en la Universidad Heriot-Watt.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ARVINAS, INC. 1,54 % | 31/03/2026 | 992.689 ( 1,54 % ) | 9 M $ | 31/05/2026 |
NEXTCURE, INC. -.--% | 22/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARVINAS, INC. | Director/Miembro de la Junta | 12/02/2026 |
| NEXTCURE, INC. | Director/Miembro de la Junta | 10/09/2020 |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Director Ejecutivo | 21/09/2017 |
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Director/Miembro de la Junta | 03/09/2019 |
Oerth Bio LLC
 Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Director/Miembro de la Junta | 01/06/2019 |
Connecticut United for Research Excellence, Inc.
 Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services for biomedical research and biotechnology to advance and support research and technology | Director/Miembro de la Junta | 01/12/2015 |
Bioct Innovation Commons | Director/Miembro de la Junta | 01/12/2015 |
| Empresas | Cargo | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/08/2016 |
GlaxoSmithKline Research & Development Ltd.
 GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
University of Glasgow
 University of Glasgow Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
 Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Connecticut United for Research Excellence, Inc.
Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services for biomedical research and biotechnology to advance and support research and technology | Commercial Services |
GlaxoSmithKline Research & Development Ltd.
GlaxoSmithKline Research & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Functions as a commercial physical research company | Commercial Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Develops molecule DNA repair inhibitors that directly target the tumor microenvironment | Health Technology |
Oerth Bio LLC
Oerth Bio LLC BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Bioct Innovation Commons | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
